Source: MarketScreener

Terns Pharmaceuticals: Terns Pharmaceuticals to Present Data from an Ongoing Phase 1 Clinical Trial of TERN-201, a SSAO Inhibitor in Development for NASH

( Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non-alcoholic steatohepatitis and cancer, today announced it will present data at the Asian Pacific Association for the Study of the Liver , taking place in Bali, Indonesia, March 4-8, 2020. The company will give an...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Senthil Sundaram's photo - CEO of Terns


Senthil Sundaram

CEO Approval Rating


Terns is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer and liver diseases. Read more